![](/img/cover-not-exists.png)
Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials
Fulcher, Greg, Mehta, Roopa, Fita, Edmond G., Ekelund, Magnus, Bain, Stephen C.Language:
english
Journal:
Diabetes Therapy
DOI:
10.1007/s13300-018-0531-0
Date:
November, 2018
File:
PDF, 808 KB
english, 2018